Our Key Figures

Total revenue in 2022

Revenu global Pierre Fabre
€0Bn

+10,1% (like for like growth vs 2021)

Revenu global Pierre Fabre
0%

generated in France

Revenu global Pierre Fabre
0%

generated internationally

Distribution of revenue per activity

DERMO-COSMETICS : 51%

ORAL CARE : 4%

PRESCRIPTION DRUGS : 13%

ONCOLOGY : 17%

MEDICAL DERMATOLOGY : 7%

FAMILY HEALTH : 5%

NATURACTIVE : 1%

OTHERS : 2%

chiffre d'affaires e-commerce

E-commerce represents

+0%

of Dermo-Cosmetics sales

chiffre d'affaires e-commerce

9 600 employees worldwide

0

in France

collaborateurs en France
0

outside France

171M€ invested in R&D (+16% VS 2021)

0M€

in Pharmaceuticals
9.9% of sales

investissement R&D
0M€

in Dermo-Cosmetics
3.9% of sales

Our patents

Medicament

Pharmaceuticals

Family of patents: 107

Patents/patent applications: 2 045

New applications in 2022: 6

Dermo cosmetique

Dermo-cosmetics

Family of patents: 116

Patents/patent applications: 1 123

New applications in 2022: 12

Updated in March 2023

We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.